Table 2.
Most common organisms reported among central line-associated bloodstream infections (CLABSI) reported to the National Healthcare Safety Network (NHSN) from oncology locations, compared to those reported from non-oncology inpatient locations, 2009–2012
| Rank | Organism | Oncology (n=5162 organisms) |
Non-oncologya (n=13,608 organisms) |
||
|---|---|---|---|---|---|
| No | % | No. | % | ||
| 1 | Coagulase-negative staphylococcus | 870 | 16.9 | 2301 | 16.9 |
| 2 | Escherichia coli | 607 | 11.8 | 494 | 3.6 |
| 3 | Enterococcus faecium | 588 | 11.4 | 1090 | 8.0 |
| 4 | Staphylococus aureus | 518 | 10.0 | 1685 | 12.4 |
| 5 | Klebsiella pneumoniae/oxytoca | 464 | 9.0 | 1070 | 7.9 |
| 6 | Viridans group streptococcusb | 291 | 5.6 | 99 | 0.7 |
| 7 | Pseudomonas aeruginosa | 279 | 5.4 | 517 | 3.8 |
| 8 | Non-albicans Candida spp. | 228 | 4.4 | 1253 | 9.2 |
| 9 | E. faecalis | 214 | 4.2 | 1204 | 8.9 |
| 10 | Enterobacter spp. | 161 | 3.1 | 681 | 5.0 |
| 11 | Enterococcus spp.c | 125 | 2.4 | 312 | 2.3 |
| 12 | Streptococcus spp.d | 124 | 2.4 | 144 | 1.1 |
| 13 | Candida albicans | 106 | 2.1 | 941 | 6.9 |
| 14 | Stenotrophomonas spp. | 61 | 1.2 | 129 | 1.0 |
| 15 | Serratia spp. | 39 | 0.8 | 352 | 2.6 |
|
| |||||
| Other | 487 | 9.4 | 1336 | 9.8 | |
a
Non-oncology ward, step-down, and critical care locations from hospitals that reported oncology CLABSI data to NHSN during 2009–2012
b
Not among 15 most common organisms in non-oncology group
c
Not faecalis/faecium, or not specified
d
Not viridans group